| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-09 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |